Prevention of aspirin-induced drop in gastric potential difference with 16, 16-dimethyl-prostaglandin E2.
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D001241:Aspirin / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D005753:Gastric Mucosa / Q000187:drug effects*; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*
D011459:Prostaglandins E, Synthetic; D015064:16,16-Dimethylprostaglandin E2; D001241:Aspirin